NO177603C - Fremgangsmåte for fremstilling av hybride proteiner, DNA sekvens, hybridvektor og eukaryot vertscelle - Google Patents

Fremgangsmåte for fremstilling av hybride proteiner, DNA sekvens, hybridvektor og eukaryot vertscelle

Info

Publication number
NO177603C
NO177603C NO875069A NO875069A NO177603C NO 177603 C NO177603 C NO 177603C NO 875069 A NO875069 A NO 875069A NO 875069 A NO875069 A NO 875069A NO 177603 C NO177603 C NO 177603C
Authority
NO
Norway
Prior art keywords
hybrid
preparation
host cell
dna sequence
eukaryotic host
Prior art date
Application number
NO875069A
Other languages
English (en)
Norwegian (no)
Other versions
NO875069L (no
NO177603B (no
NO875069D0 (no
Inventor
Bhanu Rajput
Bhabatosh Chaudhuri
Fredericus Alphonsu Asselbergs
Bernd Meyhack
Jutta Heim
Jan Van Oostrum
Sefik Alkan
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868629153A external-priority patent/GB8629153D0/en
Priority claimed from GB878709656A external-priority patent/GB8709656D0/en
Priority claimed from GB878715890A external-priority patent/GB8715890D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO875069D0 publication Critical patent/NO875069D0/no
Publication of NO875069L publication Critical patent/NO875069L/no
Publication of NO177603B publication Critical patent/NO177603B/no
Publication of NO177603C publication Critical patent/NO177603C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Amplifiers (AREA)
  • Adhesives Or Adhesive Processes (AREA)
NO875069A 1986-12-05 1987-12-04 Fremgangsmåte for fremstilling av hybride proteiner, DNA sekvens, hybridvektor og eukaryot vertscelle NO177603C (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB868629153A GB8629153D0 (en) 1986-12-05 1986-12-05 Hybrid proteins
GB878701160A GB8701160D0 (en) 1986-12-05 1987-01-20 Hybrid proteins
GB878709656A GB8709656D0 (en) 1986-12-05 1987-04-23 Hybrid proteins
GB878715890A GB8715890D0 (en) 1986-12-05 1987-07-06 Hybrid proteins

Publications (4)

Publication Number Publication Date
NO875069D0 NO875069D0 (no) 1987-12-04
NO875069L NO875069L (no) 1988-06-06
NO177603B NO177603B (no) 1995-07-10
NO177603C true NO177603C (no) 1995-10-18

Family

ID=27449853

Family Applications (1)

Application Number Title Priority Date Filing Date
NO875069A NO177603C (no) 1986-12-05 1987-12-04 Fremgangsmåte for fremstilling av hybride proteiner, DNA sekvens, hybridvektor og eukaryot vertscelle

Country Status (17)

Country Link
EP (1) EP0277313B1 (el)
JP (2) JP2641875B2 (el)
AT (1) ATE148167T1 (el)
AU (1) AU621281B2 (el)
CA (1) CA1341479C (el)
CY (1) CY2156B1 (el)
DE (1) DE3752008T2 (el)
DK (1) DK175483B1 (el)
ES (1) ES2095825T3 (el)
FI (1) FI100106B (el)
GR (1) GR3023047T3 (el)
HK (1) HK1005037A1 (el)
IE (1) IE81116B1 (el)
IL (1) IL84700A (el)
NO (1) NO177603C (el)
NZ (1) NZ222793A (el)
PT (1) PT86276B (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204255A (en) * 1986-01-31 1993-04-20 Sagami Chemical Research Center Hybrid tissue plasminogen activator/urokinase polypeptides
MY103358A (en) * 1987-04-15 1993-06-30 Novartis Ag Process for the production of protiens.
AU1893988A (en) * 1987-07-13 1989-01-19 Collaborative Research Inc. Nonglycosylated plasminogen activator and method of preparation
FR2637600B1 (fr) * 1988-10-11 1992-03-06 Pasteur Institut Peptides et polypeptides provenant de la glande sous maxillaire du rat, anticorps monoclonaux et polyclonaux correspondants, hybridomes correspondants et applications de ces produits au diagnostic, a la detection ou a des fins therapeutiques
DE68922859T2 (de) * 1988-10-27 1995-09-21 Tno Trombolytischer wirkstoff mit modifikation der domäne der kringle.
GB8826975D0 (en) * 1988-11-18 1988-12-21 Beecham Group Plc Novel compounds
DE3923339A1 (de) * 1989-05-31 1990-12-06 Boehringer Mannheim Gmbh Gewebs-plasminogen-aktivator-derivat
IE901849A1 (en) * 1989-07-19 1991-06-19 Gruenenthal Gmbh Plasmids, their preparation and their use in the manufacture¹of a plasminogen activator
GB8919803D0 (en) * 1989-09-01 1989-10-18 Ciba Geigy Pharmaceutical compositions
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
EP0462651A1 (en) * 1990-06-15 1991-12-27 Leuven Research & Development V.Z.W. Chimeric plasminogen activators
EP0548012B1 (en) * 1991-12-16 1997-09-03 Novartis AG Endoplastic reticulum-located recombinant dibasic endoprotease and uses thereof
JPH07143877A (ja) * 1993-10-01 1995-06-06 Sumitomo Pharmaceut Co Ltd 新規なｔ−ＰＡ類似体
TW517059B (en) 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
NZ595193A (en) 2005-10-21 2013-09-27 Catalyst Biosciences Inc Modified Proteases That Inhibit Complement Activation
KR20150033726A (ko) 2006-07-05 2015-04-01 카탈리스트 바이오사이언시즈, 인코포레이티드 프로테아제 스크리닝 방법 및 이에 의해 확인된 프로테아제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334498D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Compounds
US4916071A (en) * 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
EP0231883B1 (en) * 1986-01-31 1992-09-02 Sagami Chemical Research Center Hybrid plasminogen activator-like polypeptide
EP0293394B2 (en) * 1986-01-31 2003-10-29 Genetics Institute, LLC Novel thrombolytic proteins

Also Published As

Publication number Publication date
IL84700A0 (en) 1988-05-31
DK638187A (da) 1988-06-06
DE3752008D1 (de) 1997-03-06
IL84700A (en) 1992-11-15
PT86276B (pt) 1990-11-07
CY2156B1 (en) 2002-08-23
FI875324A0 (fi) 1987-12-02
GR3023047T3 (en) 1997-07-30
HK1005037A1 (en) 1998-12-18
NZ222793A (en) 1990-09-26
CA1341479C (en) 2005-04-12
ES2095825T3 (es) 1997-03-01
PT86276A (en) 1988-06-01
NO875069L (no) 1988-06-06
JPH09117292A (ja) 1997-05-06
NO177603B (no) 1995-07-10
JP2645237B2 (ja) 1997-08-25
AU8209187A (en) 1988-06-16
IE81116B1 (en) 2000-03-22
JP2641875B2 (ja) 1997-08-20
DK638187D0 (da) 1987-12-04
DE3752008T2 (de) 1997-08-14
NO875069D0 (no) 1987-12-04
FI875324A (fi) 1988-06-06
ATE148167T1 (de) 1997-02-15
IE873299L (en) 1988-06-05
AU621281B2 (en) 1992-03-12
JPS63160581A (ja) 1988-07-04
DK175483B1 (da) 2004-11-08
EP0277313A1 (en) 1988-08-10
FI100106B (fi) 1997-09-30
EP0277313B1 (en) 1997-01-22

Similar Documents

Publication Publication Date Title
NO177603C (no) Fremgangsmåte for fremstilling av hybride proteiner, DNA sekvens, hybridvektor og eukaryot vertscelle
HK1005594A1 (en) Interleukin-4 protein having bcgf and tcgf activity on human cells (human interleukin-4)
DE3786592D1 (de) Transformation von trichoderma.
EP0259475A4 (en) RECOMBINANT HUMAN ENDOTHEL CELL GROWTH FACTOR.
FI885679A (fi) Samuttryckning i eukariotiska celler.
ATE109829T1 (de) Interleukin-7.
ATE142264T1 (de) Rekombinante herstellung von a-ketten- polypeptiden von pdgf
MX168507B (es) Procedimiento para la produccion de proteinas
FI945877A (fi) Menetelmä proteiini C:n tuottamiseksi
KR860008282A (ko) 재조합 사람 레닌의 제조방법

Legal Events

Date Code Title Description
MK1K Patent expired